Inflammatory Neuropathies: the Mechanism of Intravenous Immunoglobuli
Phase 4
Completed
- Conditions
- autoimmune neuropathy/ nerve inflammation1000381610034606
- Registration Number
- NL-OMON31804
- Lead Sponsor
- niversitair Medisch Centrum Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Age > 18 years
Patients with GBS. Patients with CIDP (exacerbation) and MMN who were not treated at least three months prior to inclusion.
Exclusion Criteria
Other neuropathies (e.g. diabetic, porphiric, intoxication with medication or metal, vasculitic, Lyme neuroborreliosis, post-radiation, Charcot-Marie-Tooth, hereditary neuropathy with liability to pressure palsies). Patients with an anaphylactic reaction to IVIg in the past.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method